Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Acute kidney injury caused by haplostorm after allogenic hematopoietic stem cell transplant

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Patient flow.

Data availability

The data that support the findings of this study are available from the Research Patient Data Registry at Mass General Brigham but restrictions apply as they were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission from Mass General Brigham.


  1. Luoma S, Silvennoinen R, Rauhala A, Niittyvuopio R, Martelin E, Lindström V. et al. Long-term outcome after allogeneic stem cell transplantation in multiple myeloma. Ann Hematol. 2021;100:1553–67.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Ma L, Han X, Jiang S, Meng Q, Zhang L, Bao H. Haploidentical stem cell transplantation vs matched unrelated donor transplantation in adults with hematologic malignancies: a systematic review and meta-analysis. Hematology. 2020;25:356–65.

    Article  PubMed  Google Scholar 

  3. Abboud R, Wan F, Mariotti J, Arango M, Castagna L, Romee R, et al. Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysis. Bone Marrow Transpl. 2021;56:2763–70.

    Article  CAS  Google Scholar 

  4. Imus PH, Blackford AL, Bettinotti M, Luznik L, Fuchs EJ, Huff CA, et al. Severe cytokine release syndrome after haploidentical peripheral blood stem cell transplantation. Biol Blood Marrow Transpl. 2019;25:2431–7.

    Article  CAS  Google Scholar 

  5. Colvin GA, Berz D, Ramanathan M, Winer ES, Fast L, Elfenbein GJ. et al. Nonengraftment haploidentical cellular immunotherapy for refractory malignancies: tumor responses without chimerism. Biol Blood Marrow Transpl. 2009;15:421–31.

    Article  CAS  Google Scholar 

  6. Abboud R, Keller J, Slade M, DiPersio JF, Westervelt P, Rettig MP, et al. Severe cytokine-release syndrome after T cell-replete peripheral blood haploidentical donor transplantation is associated with poor survival and anti-IL-6 therapy is safe and well tolerated. Biol Blood Marrow Transpl. 2016;22:1851–60.

    Article  CAS  Google Scholar 

  7. Lee DW, Gardner R, Porter DL, Louis CU, Ahmed N, Jensen M, et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014;124:188–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Gupta S, Seethapathy H, Strohbehn IA, Frigault MJ, O’Donnell EK, Jacobson CA, et al. Acute kidney injury and electrolyte abnormalities after chimeric antigen receptor T-cell (CAR-T) therapy for diffuse large B-cell lymphoma. Am J Kidney Dis. 2020;76:63–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Lee MD, Strohbehn IA, Seethapathy HS, Rusibamayila N, Casey KS, Gupta S, et al. Acute kidney injury after the CAR-T therapy tisagenlecleucel. Am J Kidney Dis. 2021;77:990–2.

    Article  CAS  PubMed  Google Scholar 

  10. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pr. 2012;120:c179–184.

    Article  Google Scholar 

Download references


MES is supported by NIH K23 DK117014. MF is supported by NIH K12 CA087723. Funders did not have any role in study design, data collection, analysis, reporting, or the decision to submit for publication.

Author information

Authors and Affiliations



Research idea and study design: PH, MF, MES; data acquisition: PH, IAS; data analysis/interpretation: PH, IAS, QW, MES; statistical analysis: PH, MES; supervision or mentorship: MES. Each author contributed important intellectual content during manuscript drafting or revision, accepts personal accountability for the author’s own contributions, and agrees to ensure that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved, including with documentation in the literature if appropriate.

Corresponding author

Correspondence to Meghan E. Sise.

Ethics declarations

Competing interests

The authors whose names are listed immediately below certify that they have NO affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript. PH, IAS, QW, MES have no relevant disclosures. The authors whose names are listed immediately below report the following details of affiliation or involvement in an organization or entity with a financial or non-financial interest in the subject matter or materials discussed in this manuscript. Please specify the nature of the conflict on a separate sheet of paper if the space below is inadequate. MF receives research grant funding from Novartis and Kite, and has received consulting fees/honorarium from Novartis, Kite, Celgene/BMS, and Arcellx.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hanna, P., Strohbehn, I., Wang, Q. et al. Acute kidney injury caused by haplostorm after allogenic hematopoietic stem cell transplant. Bone Marrow Transplant 57, 1442–1444 (2022).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


Quick links